Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals

Abstract

BACKGROUND The authors assessed the use of herbal medicine by Middle Eastern patients with cancer, as reported by their oncology health care professionals (HCPs). Herbal products identified by the study HCPs were evaluated for potential negative effects. METHODS Oncology HCPs from 16 Middle Eastern countries received a 17‐item questionnaire asking them to list 5 herbal products in use by their patients with cancer. A literature search (PubMed, Micromedex, AltMedDex, and the Natural Medicine Comprehensive Database) was conducted to identify safety‐related concerns associated with the products listed. RESULTS A total of 339 HCPs completed the study questionnaire (response rate of 80.3%), identifying 44 herbal and 3 nonherbal nutritional supplements. Safety‐related concerns were associated with 29 products, including herb‐drug interactions with altered pharmacodynamics (15 herbs), direct toxic effects (18 herbs), and increased in vitro response of cancer cells to chemotherapy (7 herbs). CONCLUSIONS Herbal medicine use, which is prevalent in Middle Eastern countries, has several potentially negative effects that include direct toxic effects, negative interactions with anticancer drugs, and increased chemosensitivity of cancer cells, requiring a reduction in dosedensity. Oncology HCPs working in countries in which herbal medicine use is prevalent need to better understand the implications of this practice. The presence of integrative physicians with training in complementary and traditional medicine can help patients and their HCPs reach an informed decision regarding the safety and effective use of these products. Cancer 2016;122:598–610. © 2015 American Cancer Society.

Milk Thistle (Silybum Marianum) as a Supportive Phytotherapeutic Agent in Oncology

“…U potkana bylo při současném podání silymarinu prokázáno zvýšení plazmatické koncentrace tamoxifenu. Potenciálním mechanizmem může být zvýšení gastrointestinální absorpce léčiva nebo inhibice jeho presystémové eliminace [57]. K interakci může dojít i při současném podání silymarinu a raloxifenu.…”

Exploring an herbal “wonder cure” for cancer: a multidisciplinary approach

“…Until recently, there has not been any evidence that patients with cancer were using this herbal remedy for treating their illness. In a regional survey of oncology health care professionals from 16 Middle-Eastern countries, who were asked to provide a list of herbs which were popular among their patients, Alanda was not among the 44 herbal products mentioned 2 . However, as early as October 2013 many of the Arab-speaking patients who had been referred by their oncologists to the Integrative Oncology Program (IOP) (part of the Oncology Service of the Haifa and Western Galilee District, Clalit Health Services, Israel), reported using Alanda with the belief that the herb could “cure" their disease 3 .…”

Arum: a plant genus with great medicinal potential

“…114 Despite that, unlike other natural, plant-derived anticancer therapies, A. palaestinum has no herb-drug contradictions with synthetic drugs. 115 An interesting modern research report presented in Table 2 is about A. Conophalloides. 54 All 18 compounds identified in the essential oil of this plant do not contain nitrogen.…”